Disappointment as Alzheimer’s jab fails to meet goal on reducing memory decline, company says
A new jab for people with early-stage Alzheimer’s has failed to show it can slow down a decline in memory and thinking, according to pharmaceutical giant Roche. The drug, gantenerumab,
Read More